Investor Type | Firm |
Investing | United States |
Investment Range | $8,000,000 - $8,000,000 |
MSQ Ventures is a cross-border venture capital firm established in 2011 with a focus on partnering with U.S. based technology, consumer, and healthcare companies. They operate from their base in New York, New York. The firm specializes in cross-border projects between Western and global-regional markets, particularly in the healthcare sector. MSQ Ventures offers comprehensive advisory services targeting the flourishing biopharma industries which include market assessment, in/out-licensing, capital raising, joint ventures, and clinical trial management. They strive to help Western pharma and biotech companies navigate the challenges of global-regional markets, secure partnerships and investments through an intimate understanding of the industry, and creatively approach opportunities in substantial markets. Additionally, MSQ Ventures is dedicated to aiding in the discovery of cures for diseases by bridging Western and Eastern practices. The team ensures clients' success through a values-driven approach emphasizing teamwork, integrity, professionalism, and strives to go above and beyond in their service delivery. MSQ Ventures applies their expertise in the healthcare industry combined with a strong network of investors, industry leaders, healthcare KOLs, and government regulatory agencies. They guarantee timely results, a systematic process, and a deep focus on cross-border endeavors with insightful global-regional expertise. The firm's investment criteria involve a minimum and maximum investment amount of $8,000,000. Their credibility is supported by endorsements from various clients who have benefited from their professionalism, in-depth industry knowledge, connections, and high-quality deliverables.